Construction and characterization of an infectious molecular clone of HIV-1 subtype A of Indian origin

被引:14
作者
Rodriguez, MA
Chen, Y
Craigo, JK
Chatterjee, R
Ratner, D
Tatsumi, M
Roy, P
Neogi, D
Gupta, P
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
[3] Chittaranjan Canc Res Inst, Dept Virol, Kolkata, W Bengal, India
[4] Natl Inst Infect Dis, Dept Vet Sci, Shinjuku Ku, Tokyo 1628640, Japan
[5] Sch Trop Med, Dept Virol, Kolkata, W Bengal, India
关键词
HIV-1 molecular clone; subtype A; India;
D O I
10.1016/j.virol.2005.09.053
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
India has the second highest number of HIV-1 infected people next to South Africa. The predominant proportion of HIV-1 circulating in India is Of Subtype C origin, with a small fraction made LIP Of Subtypes A and B. In this report. we describe the construction and characterization of the first full-length infectious molecular clone p1579A-1 HIV-1 from an HIV-1 subtype A infected person from India, using long PCR and Successive ligation of the amplimers. Phylogenetic analysis of the sequence of the entire proviral DNA and LTR confirmed p1579A-1 to be an HIV-1 subtype A. Analysis of the env gene of p1579A-1 showed a conserved GPGQ motif and the absence of basic amino acids at positions I I and 25 suggesting CCR5 coreceptor usage. Analysis of env N-linked glycosylation sites revealed fewer sites in the V1 region of envelope compared to other Subtype A. Transcription factor binding site analysis of the LTR sequences identified conserved as well as unique transcription factor binding sites (TFBS) in p1579A-1. This infectious clone of HIV-1 can be useful to study the molecular mechanism of dominance of subtype C in India. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:328 / 336
页数:9
相关论文
共 30 条
[1]   Rehabilitation of patients with chronic pain of the locomotor system in an interdisciplinary functional and performance restoration program - First results after 5 months [J].
Bachmann, S ;
Oesch, P .
PHYSIKALISCHE MEDIZIN REHABILITATIONSMEDIZIN KURORTMEDIZIN, 2000, 10 (01) :11-19
[2]   HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM ASYMPTOMATIC HOMOSEXUAL MEN AND FROM AIDS PATIENTS HAVE DISTINCT BIOLOGIC AND GENETIC PROPERTIES [J].
BALACHANDRAN, R ;
THAMPATTY, P ;
ENRICO, A ;
RINALDO, C ;
GUPTA, P .
VIROLOGY, 1991, 180 (01) :229-238
[3]   USE OF CRYOPRESERVED NORMAL PERIPHERAL-BLOOD LYMPHOCYTES FOR ISOLATION OF HUMAN IMMUNODEFICIENCY VIRUS FROM SEROPOSITIVE MEN [J].
BALACHANDRAN, R ;
THAMPATTY, P ;
RINALDO, C ;
GUPTA, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (03) :595-597
[4]  
BJOMDAL A, 1997, J VIROL, V71, P7478
[5]   Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: A new surveillance tool for molecular epidemiology [J].
Cassol, S ;
Weniger, BG ;
Babu, PG ;
Salminen, MO ;
Zheng, XW ;
Htoon, MT ;
Delaney, A ;
OShaughnessy, M ;
Ou, CY .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (15) :1435-1441
[6]   Absence of coreceptor switch with disease progression in human immunodeficiency virus infections in India [J].
Cecilia, D ;
Kulkarni, SS ;
Tripathy, SP ;
Gangakhedkar, RR ;
Paranjape, RS ;
Gadkari, DA .
VIROLOGY, 2000, 271 (02) :253-258
[7]   HIV gp120 V1/V2 andC2-V3 domains glycoprotein compatibility is required for viral replication [J].
Chen, MS ;
Shi, CF ;
Kalia, V ;
Tencza, SB ;
Montelaro, RC ;
Gupta, P .
VIRUS RESEARCH, 2001, 79 (1-2) :91-101
[8]   Human immunodeficiency virus type 1 populations in blood and semen [J].
Delwart, EL ;
Mullins, JI ;
Gupta, P ;
Learn, GH ;
Holodniy, M ;
Katzenstein, D ;
Walker, BD ;
Singh, MK .
JOURNAL OF VIROLOGY, 1998, 72 (01) :617-623
[9]   GENETIC-RELATIONSHIPS DETERMINED BY A DNA HETERODUPLEX MOBILITY ASSAY - ANALYSIS OF HIV-1 ENV GENES [J].
DELWART, EL ;
SHPAER, EG ;
LOUWAGIE, J ;
MCCUTCHAN, FE ;
GREZ, M ;
RUBSAMENWAIGMANN, H ;
MULLINS, JI .
SCIENCE, 1993, 262 (5137) :1257-1261
[10]  
DELWART EL, 1995, PCR METH APPL, V4, pS202